Regenerative Medicine Weekly Trend Line
May 21st, 2011
No comments
Shares of regenerative medicine stem cell companies were again …pummeled by depreciating markets by Friday, 5/20/11. Read more…
Archive
Archive for the ‘www. Scimitar Equity.com/blog’ Category
The RegMed Daily Dialogue, 5/20/11, recovery watch … TGIF
May 20th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Updating, Earnings Report Card, Stem Cell /Regenerative Medicine Universe
May 18th, 2011
No comments
Adding to our Report Card, so far … Read more…
The RegMed Daily Dialogue, 5/18/11, Market suffers lack of clarity, conviction and risk tolerance
May 18th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The RegMed Daily Dialogue, Tuesday, 5/17/11, skepticism and some momentum
May 17th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Regenerative Medicine Weekly Trend Line
May 14th, 2011
No comments
Shares of regenerative medicine stem cell companies were pummeled hit by depreciating markets and profit taking by Friday, 5/13/11. Read more…
The RegMed Daily Dialogue, Friday, 5/13/11, a jinxed day
May 13th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The Daily Look, 5/11/11, Mid-Week, Cause and Affect
May 11th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The RegMed Daily Dialogue, Tuesday, 5/10/11, Risk on Moves
May 10th, 2011
No comments
The 6 W’s … who, what, where, when, why and what of it. Read more…
Regenerative Medicine Weekly Trend Line
May 7th, 2011
No comments
Shares of regenerative medicine stem cell companies gyrated by low volumes and earnings by Friday, 5/6/11, after being excruciatingly pushed way down and some up during the week. Read more…
Henry W. McCusker
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.